Personalised mRNA vaccine cuts melanoma recurrence risk
Sunday, 25 October 2026
An Australian-led phase III trial has reported strong results for a personalised mRNA vaccine for melanoma, called intismeran. The study enrolled 1,137 patients whose melanoma had…
Audio